Skip to search formSkip to main contentSkip to account menu

ES 8891

Known as: ES-8891 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DipeptidesMorpholines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
Effects of Repeated Oral Administration of Renin Inhibitor ES-8891 on the Renin-Angiotensin System in Human Subjects
Repeated oral doses (120mg or 240mg, once daily) of the human renin inhibitor ES-8891 were given for 10 days to 16 normotensive… 
1991
1991
Effect of renin inhibitor, ES-8891, on renal renin secretion and storage in the marmoset: comparison with captopril.
We investigated the effects of the human renin inhibitor, ES-8891, and captopril on renal renin secretion and storage in the… 
1991
1991
An Orally Active Inhibitor of Human Renin, ES-8891
1991
1991
Kidney renin gene expression after renin inhibition in the marmoset.
1. The effects of renin inhibitor ES-8891 on renin synthesis and its secretion by the kidney were investigated in normotensive… 
1990
1990
ES‐8891, an Orally Active Inhibitor of Human Renin
A newly synthesized orally active renin inhibitor, jV-morpholinoacetyl-(l-naphthyl)-L-alanyl-(4-thiazolyl)-L-alanyl (3S,4S)-4… 
1990
1990
-1194-EFFECT OF AN ORALLY ACTIVE RENIN INHIBITOR ES-8891 ON RENIN SYNTHESIS AND RENIN RELEASE : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)